Structural Characterization by NMR of a Double Phosphorylated Chimeric Peptide Vaccine for Treatment of Alzheimer’s Disease

Author： Ramírez-Gualito Karla Richter Monique Matzapetakis Manolis Singer David Berger Stefan

Publisher： MDPI

E-ISSN： 1420-3049|18|5|4929-4941

ISSN： 1420-3049

Source： Molecules, Vol.18, Iss.5, 2013-04, pp. : 4929-4941

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease

By Olasehinde Tosin A. Olaniran Ademola O. Okoh Anthony I.

Molecules, Vol. 22, Iss. 3, 2017-03 ,pp. : 480-480

MDPI

Access to resources Recommend Favorite

Stem Cell Treatment for Alzheimer’s Disease

By Li Ming Guo Kequan Ikehara Susumu

International Journal of Molecular Sciences, Vol. 15, Iss. 10, 2014-10 ,pp. : 19226-19238

MDPI

Access to resources Recommend Favorite

A Systematic Review of Antiamyloidogenic and Metal-Chelating Peptoids: Two Structural Motifs for the Treatment of Alzheimer’s Disease

By Young Sherri C.

Molecules, Vol. 23, Iss. 2, 2018-01 ,pp. : 296-296

MDPI

Access to resources Recommend Favorite

Melatonin in Alzheimer’s Disease

By Lin Li Huang Qiong-Xia Yang Shu-Sheng Chu Jiang Wang Jian-Zhi Tian Qing

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 14575-14593

MDPI

Access to resources Recommend Favorite

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

By Peron Rafaela Vatanabe Izabela Pereira Manzine Patricia Regina Camins Antoni Cominetti Márcia Regina

Pharmaceuticals, Vol. 11, Iss. 1, 2018-01 ,pp. : 12-12

MDPI

Access to resources Recommend Favorite